E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/18/2015 in the Prospect News Convertibles Daily.

Morning Commentary: Convertibles quiet post Fed; valuations steady; Medicines trades flat to higher

By Rebecca Melvin

New York, Sept. 18 – U.S. convertibles were mostly quiet as the common shares underlying the paper fluctuated on Friday.

The equities markets overall were selling off with the major indices down about 1% as investors digested the Federal Reserve’s decision to keep its Federal Funds rate unchanged at near 0%.

Convertibles, which saw an expansion of about 0.25 point early Thursday leading into the announcement, were largely unchanged afterwards, and the same was true early Friday, a New York-based trader said.

“It’s kinda dead, actually,” he said.

Medicines Co.’s 1.375% convertibles due 2017 looked to be a little stronger early Friday with the underlying shares of the Parsippany, N.J.-based health care company down almost 1%. The bonds were at the high end of their current range however at 159.6, according to Trace data.

Other names that had been notably active in the past few days were quiet, including Vipshop Holdings Ltd. and Qihoo 360 Technology Co. Ltd.

Vipshop’s 1.5% bonds due 2019 were around 111.5 with the shares down nearly 1% at $17.40.

Qihoo’s 2.5% convertibles due 2018 were unchanged at 95.125 with the shares up 0.6% at $45.85.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.